Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
5. References
E. Martin, A. Capone, J. Schneider, J. Hennig, and T. Thiel, Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy?, Ann. Neurol. 49, 518–521 (2001).
E.V. Sullivan, E. Adalsteinsson, D.M. Spielman, R.E. Hurd, and A. Pfefferbaum, N-acetylaspartate — A marker of neuronal integrity, Ann. Neurol. 50, 823 (2001).
D.L. Arnold, N. de Stefano, P.M. Matthews, and B. Trapp, N-acetylaspartate: usefulness as an indicator of viable neuronal tissue, Ann. Neurol. 50, 823 (2001).
E. Boltshauser, B. Schmitt, R.A. Wevers, U. Engelke, A.B. Burlina and A.P. Burlina, Follow-up of a child with hypoacetylaspartia, Neuropediatrics 35, 255–258 (2004).
U.F.H. Engelke, M.L.F. Liebrand-Van Sambeek, J.G.N. De Jong, J.G. Leroy, E. Morava, J.A.M. Smeitink and R.A. Wevers, N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism, Clin. Chem. 50, 58–66 (2004).
A.P. Burlina, V. Ferrari, P. Divry, W. Gradowska, C. Jakobs, M.J. Bennett, A.C. Sewell, C. Dionisi-Vici, and A.B. Burlina, N-acetylaspartylglutamate in Canavan disease: an adverse effector?, Eur. J. Pediatr. 158, 406–409 (1999).
K.F. Faull, R. Rafie, N. Pascoe, L. Marsh, and A. Pfefferbaum, N-acetyl aspartic acid (NAA) and N-acetyl aspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid, Neurochem. Res. 24, 1249–1261 (1999).
V. Brovia, A. Ricciardi, and L. Barbeito, N-acetyl-aspartylglutamate (NAAG) in human cerebrospinal fluid: determination by high performance liquid chromatography, and influence of biological variables, Amino Acids 9, 175–184 (1995).
L.M. Gehl, O.H. Saab, T. Bzdega, B. Wroblewska, and J.H. Neale, Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia, J. Neurochem. 90, 989–997 (2004).
A.P. Burlina, V. Ferrari, L. Bonafé, and A.B. Burlina, Clinical and biochemical follow-up of a patient with Canavan disease, J. Inherit. Metab. Dis. 21(suppl. 2), 48 (1998).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this paper
Cite this paper
Burlina, A.P., Schmitt, B., Engelke, U., Wevers, R.A., Burlina, A.B., Boltshauser, E. (2006). Hypoacetylaspartia: Clinical and Biochemical Follow-Up of a Patient. In: Moffett, J.R., Tieman, S.B., Weinberger, D.R., Coyle, J.T., Namboodiri, A.M.A. (eds) N-Acetylaspartate. Advances in Experimental Medicine and Biology, vol 576. Springer, Boston, MA . https://doi.org/10.1007/0-387-30172-0_20
Download citation
DOI: https://doi.org/10.1007/0-387-30172-0_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-30171-6
Online ISBN: 978-0-387-30172-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)